Citations

Clear

100 citation(s) found for "Satish, S".

Functional Changes in the Fallopian Tube: Environmental Factors, Lifestyle, Pathological Conditions and Pharmacological Agents
Roy, Opalina, Kumari, Sandhya, Adiga, Satish Kumar , Kumar, Anujith , Venkatraman, Ganesh, Kalthur, Guruprasad , Venkatraman, Ganesh , Kannan, Nagarajan , Adiga, Satish Kumar , Joshi, Manjunath Bandu , Kannan, Nagarajan

Mayo Clinic

Cells | February 2, 2026 | Volume: 15 | Issue: 3 | Pages: 269

10.3390/cells15030269 | PMID 41677632 Get It

The fallopian tubes are critical segments of the female reproductive tract and are essential for transporting gametes and embryos. It creates a conducive environment necessary for successful fertilization, early embryo development, and embryo transport. The cellular composition and function of the fallopian tube are tightly regulated by the sex hormones estradiol and progesterone. Therefore, any pathological/ metabolic condition or exposure to exogenous agents with the potential to alter endocrine levels can have a significant impact on fallopian tube function and health. This review summarizes the effects of medications, infections, pathological conditions, lifestyle choices, and environmental factors that can significantly impact the morphology, histology, cellularity, and functionality of the fallopian tube.
In Memoriam: Richard W. McCallum , MD , FACP , FRACP
Rao, Satish S.C. , Bharucha, Adil E. , Parkman, Henry P. , Saroseik, Irene, Parkman, H P , Rao, Satish , Mittal, Ravinder K.

Mayo Clinic

Neurogastroenterology & Motility | September 18, 2025 | Volume: 37 | Issue: 12 | Pages: No page available

10.1111/nmo.70169 Get It

Interobserver Reproducibility of Pelvicalyceal Invasion in Renal Cell Carcinoma Nephrectomies Among Genitourinary Pathologists
Sangoi, Ankur R. , Mubeen, Aysha , Humble, Robert , Wu, Douglas, Amin, Mahul, Aron, Manju , Brimo, Fadi , Chan, Emily , Cheng, Liang, Cheville, John C. , Collins, Katrina, Cornejo, Kristine M. , Downes, Michelle R. , Epstein, Jonathan I. , Hirsch, Michelle S. , Mohanty, Sambit K. , Netto, George J. , Osunkoya, Adeboye O. , Paner, Gladell P. , Rao, Priya, Smith, Steven C. , Tickoo, Satish K. , Tretiakova, Maria , Trpkov, Kiril , Wobker, Sara E. , Tamboli, Pheroze, Zynger, Debra L. , Cheng, Liang , Collins, Katrina , Cheng, Liang , Sangoi, Ankur R , Tretiakova, Maria S , Trpkov, Kiril , Akgül, Mahmut , Pacheco, Richard R. , Acosta, Andrés , Amin, Mahul, Dhillon, Jasreman , Kapur, Payal , Lobo, Anandi , Mehra, Rohit, Saleeb, Rola , Shah, Rajal B. , Shen, Steven S. , Tamboli, Pheroze, Williamson, Sean R.

Mayo Clinic

American Journal of Surgical Pathology | July 30, 2025 | Volume: 49 | Issue: 12 | Pages: 1307-1314

10.1097/pas.0000000000002456 | PMID 40734292 Get It

Pelvicalyceal invasion (PCI) is a relatively novel pT3a staging parameter for renal cell carcinoma (RCC) nephrectomies. While interobserver reproducibility staging studies of sinus/vascular invasion in RCC exist, a similar evaluation for PCI has not been performed. Moreover, in our experience, there is also diagnostic variability in how pathologists interpret PCI. Herein, we explore interobserver reproducibility among genitourinary (GU) pathologists. Twenty hematoxylin and eosin-stained digitized slides from RCCs (all grossly approaching the renal pelvis) were distributed to 31 GU pathologists to classify each as PCI or not PCI based on their respective clinical practices; slides with concomitant sinus/fat/vascular invasion were excluded. Slides were then evaluated for the following 4 morphologic features: tumor abutting renal pelvis, tumor pushing/indenting into the renal pelvis, polypoid configuration of tumor into the renal pelvis, and tumor eroding through renal pelvic urothelium. Interobserver reproducibility was assessed, and the morphologic features were correlated with PCI. Relationships between pathologists’ interpretations, morphologic features, and PCI were evaluated using hierarchical clustering. Although the diagnosis of PCI was relatively uniform with a majority agreement (>67%) reached in 16/20 slides, overall interobserver reproducibility was only moderate (kappa=0.601). While all 4 morphologic features were sensitive for PCI, polypoid configuration of the tumor into the renal pelvis and the tumor eroding through the renal pelvic urothelium were most specific (90%, 100%, respectively). Although we show general consensus among genitourinary pathologists on PCI assessment, clarifying the diagnostic guidelines with specific criteria should be included in pathologic staging systems.
Assessment and classification of sex cord‐stromal tumours of the testis: recommendations from the testicular sex cord‐stromal tumour ( TESST ) group, an Expert Panel of the Genitourinary Pathology Society
Acosta, Andrés , Compérat, Éva , Cornejo, Kristine M. , Gupta, Sounak , Cheville, John C. , Idrees, Muhammad T. , Raspollini, Maria Rosaria , Reyes‐Múgica, Miguel , Tickoo, Satish K. , Ulbright, Thomas M. , Sholl, Lynette M. , Gonzalez‐Peramato, Pilar, Acosta, Andrés M , Comperat, Eva , Raspollini, Maria Rosaria , Tsuzuki, Toyonori , Williamson, Sean R , Siegmund, Stephanie , Sholl, Lynette , Berney, Daniel M , Reyes-Mugica, Miguel , Colecchia, Maurizio , Gill, Anthony J. , Kao, Chia‐Sui , Maclean, Fiona M. , Matoso, Andres , Michalova, Kvetoslava , Tsuzuki, Toyonori , Williamson, Sean R. , Berney, Daniel M.

Mayo Clinic

Histopathology | June 18, 2025 | Volume: 87 | Issue: 5 | Pages: 660-676

10.1111/his.15482 | PMID 40528632 Get It

Aims Testicular sex cord‐stromal tumours (TSCSTs) are relatively rare, accounting for ~5% of all testicular neoplasms. They were historically classified into Leydig cell tumour, Sertoli cell tumour, granulosa cell tumour, and unclassified sex cord‐stromal tumour. More recently, classification was expanded to incorporate additional histologic types, including some associated with inherited cancer predisposition syndromes. However, the classification of TSCSTs still relies entirely on morphology, with some tumour types being defined based on their resemblance to ovarian counterparts. In recent years, molecular studies have identified drivers and genomic alterations associated with aggressive behaviour and progression; however, these findings have not yet impacted classification and management. Methods and results Under sponsorship of the International Society of Urological Pathology (ISUP) and the Genitourinary Pathology Society (GUPS), a group of genitourinary pathologists was assembled in 2023 with the aim of assessing how to use these new data to improve the classification and management of TSCSTs. Conclusions This paper summarizes the recommendations derived from the consensus activities and the first meeting of the te sticular s ex cord‐ s tromal t umour (TESST) group (held at Johns Hopkins Hospital, Baltimore, USA, 3/23/2024).
Development and Validation of a Bowel Diary for Fecal Incontinence: Comparison With a Questionnaire
Butt, Mohsin F. , Rao, Satish S.C. , Whitehead, William E. , Twist, Stefanie, Lowry, Ann C., Bailey, Kent R. , Bharucha, Adil E. , Bharucha, A E , Rao, Satish , Butt, Mohsin F , Wu, Jennifer M.

Mayo Clinic

Neurogastroenterology & Motility | June 17, 2025 | Volume: 37 | Issue: 11 | Pages: No page available

10.1111/nmo.70080 | PMID 40524563 Get It

ABSTRACTBackground and AimsBowel diaries are used to characterize the severity of fecal incontinence (FI) but have not been adequately validated for this purpose. Our aims were to validate a new bowel diary and to compare the characteristics of FI as assessed with a bowel diary and a validated questionnaire.MethodsIn this four‐center prospective study, patients with a history of FI and asymptomatic controls completed a 28‐day bowel diary and validated questionnaires to evaluate bowel habits and FI, quality of life related to FI (FIQoL), and PROMIS scales for anxiety, depression, and self‐efficacy.ResultsAmong 59 participants with FI and 29 asymptomatic controls, the bowel diary was 97% sensitive and 93% specific for distinguishing between FI participants and controls. Over 28 days, FI participants experienced an average [SD] of 31.1 [50.7] FI episodes, consisting of staining (12.6 [14.9]), some stool (12.5 [20.3]), or a full bowel movement (4.4 [8.5]). Correlations between the questionnaire and diary were statistically significant for frequency (Spearman ρ = 0.5, p < 0.001), amount (ρ = 0.4, p < 0.001), and awareness of FI (ρ = 0.3, p = 0.04). In 71% of participants, there was agreement between the consistency of FI as reported in the questionnaire and the diary. More severe FI was associated with poorer FIQoL (p = 0.002). Anxiety, depression, and self‐efficacy scores did not significantly affect the agreement between the frequency of FI reported in the diary and questionnaire.ConclusionThis bowel diary effectively discriminates between healthy participants and those with FI. There is significant, albeit modest, agreement between the characteristics of FI recorded with a diary and a questionnaire.
Guidelines Against Discrimination and Bias in Anatomical Research Papers (GDBARP): Recommendations From Anatomical Journal Editors
Takeda, Sén, Sol, Mariano del , Ravi, Kumar Satish , Singh, Vishram, Apaydın, Nihal, Kim, Hee‐Jin , Adds, Philip J. , Loukas, Marios , Tubbs, R. Shane, Del Sol, Mariano , Ravi, Kumar Satish , Apaydin, Nihal , Adds, Philip , Loukas, Marios , Iwanaga, Joe , Walocha, Jerzy Andrzej , Ribatti, Doménico , Moryś, Janusz , Paulsen, Friedrich P. , Duparc, Fabrice

Mayo Clinic

Clinical Anatomy | May 19, 2025 | Volume: 38 | Issue: 5 | Pages: 613-618

10.1002/ca.24293 | PMID 40384060 Get It

ABSTRACTMost discussions about discrimination and bias in anatomical research papers have been limited to terminology relating to race/ethnicity and gender/sex. However, as editors of anatomical journals, the authors of this article have frequently observed broader instances of potential discrimination and bias within anatomical research. These often stem from differences among authors' backgrounds, traditions, cultures, religions, provenance/origins, and workplace affiliations. In view of the limited discourse on this topic, we seek in this article to establish a consensus among editors of anatomical journals and to propose new Guidelines Against Discrimination and Bias in Anatomical Research Papers (GDBARP). We have identified multiple factors that can contribute to discrimination and bias, underscoring the need for greater awareness and proactive measures. It is imperative in anatomical research to respect authors, reviewers, and editors regardless of their background, culture, traditions, sex, ethnicity, language, religion, or ethical perspectives.
Impact of Constipation Therapies on Severity of Gastroparesis and Constipation Symptoms in Relation to Gastric and Colonic Transit
Surjanhata, Brian , Moshiree, Baharak , Lee, Allen , McCallum, Richard W. , Sarosiek, Irene , Nguyen, Linda Anh B. , Schulman, Michael I., Wo, John M. , Parkman, Henry P. , Surjanhata, Brian C , Nguyen, Linda A , Hasler, William L. , Rao, Satish , Parkman, H P , Lee, Allen A , Kuo, Braden , Rao, Satish S.C.

Mayo Clinic

Neurogastroenterology & Motility | March 11, 2025 | Volume: 37 | Issue: 6 | Pages: No page available

10.1111/nmo.70013 | PMID 40033166 Get It

ABSTRACTIntroductionStudies demonstrate an overlap of constipation with gastroparesis and functional dyspepsia, but the impact of treatments that target constipation on improving upper gastrointestinal (UGI) symptoms is unexplored. We quantified the effects of constipation medication therapies on UGI and constipation symptom severity in subjects presenting with symptoms of gastroparesis.MethodsFifty‐six subjects with symptoms of gastroparesis underwent concurrent wireless motility capsule and gastric emptying scintigraphy and were recommended to receive either a new medication therapy for constipation or a change in constipation therapy based on investigator interpretation of test results. Gastroparesis Cardinal Symptom Index (GCSI), upper abdominal pain, and constipation scores were compared between baseline and 6 months. Data were compared between delayed or non‐delayed gastric emptying and the presence or absence of slow colonic transit.Key ResultsSubjects with slow colonic transit had improvements in GCSI (p = 0.007) and constipation scores (p = 0.004) after treatment with a new or changed constipation medication, with the delayed emptying subgroup driving GCSI improvements (p = 0.004). Reductions in nausea/vomiting (p = 0.02) and early satiety/fullness subscores (p = 0.002) with trends to improved bloating/distention subscores (p = 0.06) were observed in this subgroup, but upper abdominal pain was unchanged. Subjects with normal colonic transit showed no improvement in GCSI scores regardless of gastric emptying status (p > 0.05).Conclusions and InferencesIdentifying and treating delayed colonic transit in gastroparetic (delayed gastric emptying) subjects improves global UGI symptoms as well as selected individual symptoms. Evaluation of whole gut motility as well as recognizing and managing extragastric delay may promote improved outcomes in these patients.Trial RegistrationClinicalTrials.gov: NCT02022826
US multicenter outcomes of endoscopic ultrasound-guided gallbladder drainage with lumen-apposing metal stents for acute cholecystitis
David, Yakira , Kakked, Gaurav, Confer, Bradley , Shah, Ruchit N. , Khara, Harshit S. , Diehl, David L. , Krafft, Matthew , Shah-Khan, Sardar M. , Nasr, John , Benias, Petros C. , Muniraj, Thiruvengadam , Aslanian, Harry R., Chahal, Prabhleen , Rodriguez, John , DuBroff, Jason, Latour, Rabi De, Khanna, Lauren , Haber, Gregory , Hoerter, Nicholas A. , Pandey, Nishi , Bakhit, Mena , Kowalski, Thomas E., Loren, David E. , Chiang, Austin , Schlachterman, Alexander , Nieto, Jose , Ichkhanian, Yervant , Khashab, Mouen A. , Halabi, Maan El , Kwon, Richard S. , Hernandez-Lara, Ariosto, Poneros, John M., Sethi, Amrita, Gonda, Tamas A. , Kushnir, Vladimir , Cosgrove, Natalie , Mullady, Daniel , Al-Shahrani, Abdullah , Buscaglia, Jonathan M. , Bucobo, Juan Carlos , Rolston, Vineet S. , Kedia, Prashant , Kasmin, Franklin, Kumta, Nikhil A. , DiMaio, Christopher J. , Krafft, Matthew Richard , Trindade, Arvind J. , Adler, Douglas G. , Tzimas, Demetrios J. , Goodman, Adam J. , Nieto, José , Deshmukh, Ameya A. , Prabhu, Anoop , Storm, Andrew C. , Berzin, Tyler M. , Sethi, Amrita , D'Souza, Lionel S. , Nagula, Satish

Mayo Clinic

Endoscopy International Open | January 13, 2025 | Volume: 13 | Issue: CP | Pages: No page available

10.1055/a-2495-5542 | PMID 39958659 Get It

AbstractEUS-guided gallbladder drainage (EUS-GBD) using lumen apposing metal stents (LAMS) has excellent technical and short-term clinical success for acute cholecystitis (AC). The goals of this study were to determine the long-term clinical outcomes and adverse events (AEs) of EUS-GBD with LAMS.A multicenter, retrospective study was conducted at 18 US tertiary care institutions. Inclusion criteria: any AC patient with attempted EUS-GBD with LAMS and minimum 30-day post-procedure follow-up. Long-term clinical success was defined as absence of recurrent acute cholecystitis (RAC) > 30 days and long-term AE was defined as occurring > 30 days from the index procedure.A total of 109 patients were included. Technical success was achieved in 108 of 109 (99.1%) and initial clinical success in 106 of 109 (97.2%). Long-term clinical success was achieved in 98 of 109 (89.9%) over a median follow-up of 140 days (range 30–1188). On multivariable analysis (MVA), acalculous cholecystitis (odds ratio [OR] 15.93, 95% confidence interval [CI] 1.22–208.52, P = 0.04) and the occurrence of a LAMS-specific AE (OR 63.60, 95% CI 5.08–799.29, P <0.01) were associated with RAC. AEs occurred in 38 of 109 patients (34.9%) at any time, and in 10 of 109 (9.17%) > 30 days from the index procedure. Most long-term AEs (7 of 109; 6.42%) were LAMS-specific. No technical or clinical factors were associated with occurrence of AEs. LAMS were removed in 24 of 109 patients (22%). There was no difference in RAC or AEs whether LAMS was removed or not.EUS-GBD with LAMS has a high rate of long-term clinical success and modest AE rates in patients with AC and is a reasonable destination therapy for high-risk surgical candidates.
The 2023 Society for Vascular Surgery, American Venous Forum, and American Vein and Lymphatic Society Clinical Practice Guidelines for the Management of Varicose Veins of the Lower Extremities. Part II: Endorsed by the Society of Interventional Radiology a
Lawrence, Peter F. , Wasan, Suman , Meissner, Mark H. , Almeida, José I. , Brown, Kellie R. , Bush, Ruth L., Iorio, Michael Di, Fish, John, Gloviczki, Monika L. , Jayaraj, Arjun , Obi, Andrea T., Ozsvath, Kathleen J., Singh, Michael J. , Vayuvegula, Satish, Welch, Harold J. , Gloviczki, Péter , Fukaya, Eri , Hingorani, Anil , Kolluri, Raghu , Murad, M. Hassan , Obi, Andrea T.

Mayo Clinic

Annals of Phlebology | October 28, 2024 | Volume: 22 | Issue: Suppl 1 | Pages: S1-S77

10.37923/phle.2024.22.s.s1 Get It

S729 Comparative Evaluation of Gas-Sensing Capsule and Wireless Motility Capsule for Transit Time Assessment in Motility Disorders
Cline, Michael, Masoud, Amir , McCallum, Richard W. , Moshiree, Baharak, Sanchez, Mayra, Sarosiek, Irene , Stocker, Abigail, Surjanhata, Brian , Chey, William D. , Kuo, Braden , Lee, Allen Ting Chun , Abell, Thomas L. , Attaluri, Ashok, Hasler, William L. , Ho, Vincent , Lembo, Anthony , Quigley, Eamonn M.M. , Rao, Satish S.C. , Zhou, Jerry

Mayo Clinic

American Journal of Gastroenterology | October 24, 2024 | Volume: 119 | Issue: 10S | Pages: S500-S501

10.14309/01.ajg.0001032284.18811.76 Get It